{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:51Z","timestamp":1761519051680},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1093\/annonc\/mds592","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T02:10:32Z","timestamp":1353377432000},"page":"1163-1170","source":"Crossref","is-referenced-by-count":8,"title":["Management of the axilla in early breast cancer patients in the genomic era"],"prefix":"10.1016","volume":"24","author":[{"given":"M.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Balma\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Mattos-Arruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Saura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.T.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Di Cosimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds592_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-190707000-00001","article-title":"The results of radical operations for the cure of carcinoma of the breast","volume":"46","author":"Halsted","year":"1907","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mds592_bb0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mds592_bb0020","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1245\/ASO.2003.03.073","article-title":"Breast cancer survival according to number of nodes removed","volume":"10","author":"Krag","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","article-title":"The impact of prophylactic axillary node dissection on breast cancer survival\u2014a Bayesian meta-analysis","volume":"6","author":"Orr","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0030","article-title":"Update of International Breast Cancer Study Group Trial 23-01 to compare axillary dissection versus no axillary dissection in patients with clinically node negative breast cancer and micrometastases in the sentinel node","author":"Galimberti","year":"2011","journal-title":"San Antonio Breast Cancer Symposium"},{"key":"10.1093\/annonc\/mds592_bb0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"suppl","key":"10.1093\/annonc\/mds592_bb0040","volume":"29","author":"Gonzalez-Angulo","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0045","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.ejca.2011.09.016","article-title":"The EORTC 10041\/BIG 03\u201304 MINDACT trial is feasible: results of the pilot phase","volume":"47","author":"Rutgers","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mds592_bb0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10549-010-1329-6","article-title":"The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort","volume":"126","author":"Ademuyiwa","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds592_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jso.21244","article-title":"The influence of a gene expression profile on breast cancer decisions","volume":"99","author":"Henry","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15040","article-title":"Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation","volume":"15","author":"Cooper","year":"2011","journal-title":"Health Technol Assess"},{"key":"10.1093\/annonc\/mds592_bb0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","article-title":"Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla","volume":"254","author":"Houssami","year":"2011","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mds592_bb0070","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","article-title":"Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0075","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","article-title":"Sentinel node identification rate and nodal involvement in the EORTC 10981\u201322023 AMAROS trial","volume":"17","author":"Straver","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00268-001-0003-x","article-title":"Predicting axillary nodal positivity in 2282 patients with breast carcinoma","volume":"25","author":"Silverstein","year":"2001","journal-title":"World J Surg"},{"key":"10.1093\/annonc\/mds592_bb0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archsurg.1996.01430150079015","article-title":"The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening","volume":"131","author":"Cady","year":"1996","journal-title":"Arch Surg"},{"key":"10.1093\/annonc\/mds592_bb0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9610(96)00228-0","article-title":"The value of axillary dissection in T1a breast cancer","volume":"172","author":"McGee","year":"1996","journal-title":"Am J Surg"},{"key":"10.1093\/annonc\/mds592_bb0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejso.2011.01.006","article-title":"Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN","volume":"37","author":"van la Parra","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0100","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"10.1093\/annonc\/mds592_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1245\/s10434-010-1264-0","article-title":"Controversies in breast surgery","volume":"17","author":"Boughey","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","article-title":"Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer","volume":"10","author":"Hwang","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","article-title":"An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement","volume":"91","author":"Barranger","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds592_bb0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.amjsurg.2005.06.008","article-title":"Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram","volume":"190","author":"Degnim","year":"2005","journal-title":"Am J Surg"},{"key":"10.1093\/annonc\/mds592_bb0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-8-66","article-title":"New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients","volume":"8","author":"Kohrt","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1093\/annonc\/mds592_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bjs.5943","article-title":"A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive","volume":"95","author":"Pal","year":"2008","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mds592_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/000313480407000202","article-title":"Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer","volume":"70","author":"Saidi","year":"2004","journal-title":"Am Surg"},{"key":"10.1093\/annonc\/mds592_bb0140","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","article-title":"Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study","volume":"27","author":"Coutant","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0145","first-page":"66","article-title":"Current controversies in the therapeutic approach to early breast cancer in the elderly","volume":"22","author":"Cerrotta","year":"1997","journal-title":"Rays"},{"key":"10.1093\/annonc\/mds592_bb0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/bjs.1800691202","article-title":"Manchester regional breast study\u20135 and 10 year results","volume":"69","author":"Lythgoe","year":"1982","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mds592_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(86)80002-0","article-title":"Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer\u2014a twenty three year experience","volume":"5","author":"Leung","year":"1986","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1093\/annonc\/mds592_bb0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1245\/s10434-011-2082-8","article-title":"Favorable outcome of secondary axillary dissection in breast cancer patients with axillary nodal relapse","volume":"19","author":"Shen","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0165","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/JCO.1991.9.6.988","article-title":"Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma","volume":"9","author":"Recht","year":"1991","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1093\/annonc\/mds592_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jss.2012.02.020","article-title":"Ipsilateral nodal recurrence after axillary dissection for breast cancer","volume":"177","author":"Walsh","year":"2012","journal-title":"J Surg Res"},{"key":"10.1093\/annonc\/mds592_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejso.2004.12.017","article-title":"Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer","volume":"31","author":"Voogd","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000658-199709000-00007","article-title":"Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection","volume":"226","author":"Dees","year":"1997","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mds592_bb0185","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa0910320","article-title":"Adjuvant docetaxel for high-risk, node-negative breast cancer","volume":"363","author":"Martin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0190","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0140-6736(92)91591-U","article-title":"Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie","volume":"339","author":"Cabanes","year":"1992","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds592_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2004.12.108","article-title":"Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up","volume":"22","author":"Louis-Sylvestre","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0200","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM198503143121102","article-title":"Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation","volume":"312","author":"Fisher","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0205","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0011-3840(05)80015-2","article-title":"Axillary dissection: current practice and technique","volume":"32","author":"Petrek","year":"1995","journal-title":"Curr Probl Surg"},{"key":"10.1093\/annonc\/mds592_bb0215","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cncr.24174","article-title":"Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis","volume":"115","author":"Sanghani","year":"2009","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds592_bb0220","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjsurg.2009.10.012","article-title":"Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma","volume":"200","author":"Bafford","year":"2010","journal-title":"Am J Surg"},{"key":"10.1093\/annonc\/mds592_bb0225","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","article-title":"Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32","volume":"28","author":"Land","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PPO.0b013e31817fbe5e","article-title":"Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction","volume":"14","author":"Sclafani","year":"2008","journal-title":"Cancer J"},{"key":"10.1093\/annonc\/mds592_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000129358.80798.62","article-title":"Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer","volume":"240","author":"Silberman","year":"2004","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mds592_bb0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0266462304001345","article-title":"Cost comparison of two surgical strategies in the treatment of breast cancer: sentinel lymph node biopsy versus axillary lymph node dissection","volume":"20","author":"Perrier","year":"2004","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1093\/annonc\/mds592_bb0245","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","article-title":"Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study","volume":"27","author":"Shih","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-010-1135-1","article-title":"The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer","volume":"124","author":"Gabos","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds592_bb0255","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","article-title":"Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy","volume":"26","author":"Nguyen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0260","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","article-title":"Breast cancer subtypes and the risk of local and regional relapse","volume":"28","author":"Voduc","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0265","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-011-1709-6","article-title":"A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments","volume":"130","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds592_bb0270","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1245\/s10434-011-1665-8","article-title":"Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer","volume":"18","author":"Meyers","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0275","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/annonc\/mdr129","article-title":"Breast cancer subtypes and outcome after local and regional relapse","volume":"23","author":"Montagna","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds592_bb0280","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10549-011-1495-1","article-title":"Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation","volume":"128","author":"Panoff","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds592_bb0285","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejso.2005.01.001","article-title":"The prognostic significance of axillary lymph-node micrometastases in breast cancer patients","volume":"31","author":"Kuijt","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0290","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2007.12.6425","article-title":"Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up","volume":"26","author":"Tan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0295","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","article-title":"Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy","volume":"16","author":"Rescigno","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0300","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1245\/s10434-009-0549-7","article-title":"Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty","volume":"16","author":"Wasif","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds592_bb0305","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1200\/JCO.2009.24.5001","article-title":"Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes","volume":"28","author":"Andersson","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0310","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2008.19.0686","article-title":"Impact of micrometastases in the sentinel node of patients with invasive breast cancer","volume":"27","author":"Hansen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0315","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolated tumor cells and the outcome of breast cancer","volume":"361","author":"De Boer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0320","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.18_suppl.cra504","article-title":"ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1\/T2 N0 M0 breast cancer","volume":"28","author":"Cote","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer","volume":"364","author":"Weaver","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0330","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1093\/annonc\/mds592_bb0335","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0340","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.12-6-631","article-title":"Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen","volume":"12","author":"Paik","year":"2007","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mds592_bb0350","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer","volume":"24","author":"Paik","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0355","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2009.23.7610","article-title":"Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"28","author":"Mamounas","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0360","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1200\/JCO.2005.02.0818","article-title":"Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer","volume":"23","author":"Gianni","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0365","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van 't Veer","year":"2002","journal-title":"Nature"},{"key":"10.1093\/annonc\/mds592_bb0370","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds592_bb0375","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jnci\/djj329","article-title":"Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer","volume":"98","author":"Buyse","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds592_bb0380","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds592_bb0385","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/bjc.1998.581","article-title":"Long-term survival in node-positive breast cancer treated by locoregional therapy alone","volume":"78","author":"Joensuu","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds592_bb0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mds592_bb0395","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-008-0130-2","article-title":"The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1\u20133 positive lymph nodes in an independent validation study","volume":"116","author":"Mook","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds592_bb0400","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2007.15.1068","article-title":"Development of the 21-gene assay and its application in clinical practice and clinical trials","volume":"26","author":"Sparano","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0405","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1200\/JCO.2007.14.3222","article-title":"Clinical application of the 70-gene profile: the MINDACT trial","volume":"26","author":"Cardoso","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds592_bb0410","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/cncr.27463","article-title":"A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy","volume":"118","author":"Stubblefield","year":"2012","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds592_bb0415","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/cncr.27469","article-title":"Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer","volume":"118","author":"Binkley","year":"2012","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds592_bb0420","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/cncr.27462","article-title":"Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors","volume":"118","author":"Schmitz","year":"2012","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419372308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419372308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/5\/1163\/568594\/mds592.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T21:47:30Z","timestamp":1687816050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419372308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0923753419372308"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds592","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}